Dollar-a-dose rotavirus vaccine on Indian horizon

India has announced positive late-stage clinical results from its first indigenous oral rotavirus vaccine developed through a unique public-private partnership.

India has announced positive late-stage clinical results from its first indigenous oral rotavirus vaccine developed through a unique public-private partnership.

The vaccine, if approved by the national regulator, is expected to be priced at $1 per dose, far cheaper than...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Alimentary/Metabolic

More from Therapeutic Category